Literature DB >> 2884551

Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids.

N A Pikaar, M Wedel, E J van der Beek, W van Dokkum, H J Kempen, C Kluft, T Ockhuizen, R J Hermus.   

Abstract

To investigate the effect of moderate alcohol consumption on blood constituents related to cardiovascular disease, 12 male volunteers consumed (instead of their usual alcoholic drinks) four different standardized amounts of red wine in addition to their habitual diet. Each dose was given to the subjects during a period of 5 weeks in a randomized order, all subjects receiving the four doses. They consisted of 0, 2, and 4 glasses/d, providing 0, 23, and 46 g alcohol/d as well as in "binge drinking" (14 glasses in the weekend, comparable to an average of 2 glasses/d). The results showed a clear dose-related response to the drinking for several blood constituents. Most marked was a decrease in the tissue-type plasminogen activator activity and to a lesser degree an increase in plasminogen levels. Collagen-induced platelet aggregation was reduced, affecting all parameters measured. Levels of HDL3-cholesterol, gammaglutamyltransferase, and urate showed a small but significant increase. No change was noted in the levels of alkaline phosphatase, alanine-aminotransferase, aspartate-aminotransferase, bile acids, folate, fibrinogen, the ADP-induced platelet aggregation, platelet secretion, or in hematologic values. The results are only partially in accordance with the presumed protective action of moderate drinking on the cardiovascular system and show a stronger response to the consumption of alcohol in coagulation and fibrinolysis factors than in blood lipids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884551     DOI: 10.1016/0026-0495(87)90163-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  26 in total

1.  Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction.

Authors:  V L Serebruany; D R Lowry; S Y Fuzailov; D J Levine; C M O'Connor; P A Gurbel
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

2.  Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality.

Authors:  S G Wannamethee; A G Shaper
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

Review 3.  Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms.

Authors:  Maike Krenz; Ronald J Korthuis
Journal:  J Mol Cell Cardiol       Date:  2011-10-23       Impact factor: 5.000

4.  Effect of modest alcohol consumption over 1-2 weeks on the coronary microcirculation of normal subjects.

Authors:  Sanjiv Kaul; Todd Belcik; Saul Kalvaitis; Ananda R Jayaweera; Si-Wan Choi; Kevin Wei
Journal:  Eur J Echocardiogr       Date:  2010-04-08

Review 5.  Cardiovascular effects of alcohol.

Authors:  D M Davidson
Journal:  West J Med       Date:  1989-10

6.  Antecedent ethanol ingestion prevents postischemic leukocyte adhesion and P-selectin expression by a protein kinase C-dependent mechanism.

Authors:  Catherine Dayton; Taiji Yamaguchi; Kazuhiro Kamada; Patsy Carter; Ronald J Korthuis
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 7.  Identifying and managing problem drinkers.

Authors:  M Kahan
Journal:  Can Fam Physician       Date:  1996-04       Impact factor: 3.275

8.  Characterization of gamma-glutamyl transpeptidase activity of cultured endothelial cells from porcine brain capillaries.

Authors:  U Mischeck; J Meyer; H J Galla
Journal:  Cell Tissue Res       Date:  1989-04       Impact factor: 5.249

9.  Liver disease and platelet function in alcoholics.

Authors:  D P Mikhailidis; M A Barradas; J Y Jeremy; P Dandona
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-24

10.  Effect of moderate dose of alcohol with evening meal on fibrinolytic factors.

Authors:  H F Hendriks; J Veenstra; E J Velthuis-te Wierik; G Schaafsma; C Kluft
Journal:  BMJ       Date:  1994-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.